Johnson Matthey PLC (LON:JMAT) Insider Liam Condon Purchases 30 Shares

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon purchased 30 shares of the stock in a transaction on Wednesday, January 22nd. The shares were purchased at an average price of GBX 1,362 ($17.00) per share, for a total transaction of £408.60 ($510.05).

Johnson Matthey Stock Performance

LON JMAT opened at GBX 1,376 ($17.18) on Friday. The company has a 50-day simple moving average of GBX 1,378.95 and a two-hundred day simple moving average of GBX 1,508.96. Johnson Matthey PLC has a 12-month low of GBX 1,295.54 ($16.17) and a 12-month high of GBX 1,917.07 ($23.93). The firm has a market cap of £2.40 billion, a price-to-earnings ratio of 2,372.41, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 63.15.

Johnson Matthey (LON:JMATGet Free Report) last released its earnings results on Wednesday, November 27th. The company reported GBX 57.40 ($0.72) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.39% and a net margin of 0.84%. On average, equities analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current year.

Johnson Matthey Cuts Dividend

The company also recently announced a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be issued a dividend of GBX 22 ($0.27) per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio is currently 13,275.86%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on JMAT shares. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.47) price objective on shares of Johnson Matthey in a research report on Tuesday, December 17th. Berenberg Bank reduced their price target on shares of Johnson Matthey from GBX 1,650 ($20.60) to GBX 1,500 ($18.72) and set a “hold” rating on the stock in a research report on Thursday, November 28th.

Read Our Latest Stock Report on Johnson Matthey

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.